NeuroClimax is a proprietary nasal nootropic formulation spray for brain regeneration enhancer with organic nootropic grade active ingredients. It supports memory, learning, cognitive enhancement, brain energy and focus through novel regenerative cognitive increase using brain plasticity mechanisms in neurons.
How does it work? Two nootropic agents' classes are biologics derived from a plant (Cyclic AMP enhancers enantiomers + forskolin) and synthesized glutaminergic peptide agonists of memory receptors. In combination, the nootropic agents provide potent neurotrophic support by increasing the level of Cyclic AMP, Brain-Derived Neurotrophic Factor and Nerve Growth Factor. By increase the levels of Cyclic AMP, BDNF and NGF in the brain, these neurotrophic factors are known to increase brain energy by increasing the level of ATP, increase the formation of neuronal networks and circuits, and activate neuronal re-development and growth of new neurons by NGF.
Overall, this unique powerful brain targeting enhancing technology is only one known to enable brain repair mechanisms (kinases proteins of brain connectivity increase), and new neuronal formations that were lost during neurodegeneration (chemical lesions) and reinstate motor, energy, and intellectual brain capabilities with the end goal is to increase quality of life (Dagda & Dagda, 2022)
By combining both of the class of nootropics as a nootropic stack directly to the brain, these two active ingredients have been shown in preclinical studies to activate a positive loop in the brain that provides an additive effect in enhancing brain health, brain energy (Dagda & Dagda, 2022)
NeuroClimax brand products are manufactured and distributed by CNS Curative Technologies and is a registered trademark brand owned and managed by CNS Curative Technologies LLC under USPTO numbers: 98309088, 98309099 and 98309108.
https://www.cnscurative.com
https://www.cnscurative.store
Why order:
- Only made in Nevada
- USDA certified for quality, and safety
- Sterile formulation
- Unique high potency brain targeting antidepressive mechanism in brain
- Fast acting in less than 15 minutes
-Long lasting more than 8 hours
Safety and quality of manufacture:
USDA certificate of analysis for safety consumption of sterile, free of heavy metals, and active pharmaceutical quality (scroll images) for organic drugs nutraceutics
Manufactured and distributed by CNS Curative Technologies LLC under ISO 14644-1:2015 ISO Class 5, 6, and 7 pharmaceutical bio bay sterile rooms.
https://www.cnscurative.com
https://www.cnscurative.store
Active ingredients: 99 percent pharmaceutical grade up to 0.5% + cyclic amp enhancers + forskolin
99 percent pharmaceutical grade glutaminergic peptide agonists of memory receptors up to 0.05%
enhanced batch active ingredients added: 99% Centrophenoxin up to 0.3% (cholinergic enhancer)
in sterile pbs pH 7.35 with excipients
Excipients:
Proprietary organic excipients give direct brain targeting, high brain bioavailability, and potentiation of active ingredients with soothers for convenience dosing: less than 0.2% on: propylene glycol, sodium sorbate, EDTA, and natural gamma cyclodextrins.
Disease modifying benefits and features of NeuroClimax
- Executive functioning
- Focus
- Increased motor capacity
- complete daily activities
- work capacity
![]()
Trademarks numbers: 98309088, 98309099, 98309108.
US patent Options agreement: NVRIC-OPTN-25-CNSCurative
Made and manufacture by CNS Curative Technologies
300 East 2nd street, 15th floor, suite 1512
The science and technology
NeuroClimax's pre-clinical articles
-
- Ruben & Dagda, Raul & Mayorga, Emmanuel & Martinez, Bridget & Gallahue, Aine. (2022). Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats. International Journal of Molecular Sciences. 24. 690. 10.3390/ijms24010690
-
- Patented pharmaceutical technology against LewyBody dementia Parkinson's disease US11612583B2: "Disease modifying methods for treating neurodegenerative diseases using nootropic agents" Raul Y Dagda, and Ruben K. Dagda
- - National Science foundation I-corps awards to CNS Curative Technologies: Patients interviews for medical necessities for NeuroClimax development
Disclaimers:
Not approved by FDA to label, indicate, or treat diseases.
